Double blind controlled phase III multicenter clinical trial with interferon gamma in rheumatoid arthritis. German Lymphokine Study Group (Q67818617)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1290019 AND SRC:MED&resulttype=core&format=json

17 September 2019

title

Double blind controlled phase III multicenter clinical trial with interferon gamma in rheumatoid arthritis. German Lymphokine Study Group (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1290019 AND SRC:MED&resulttype=core&format=json

multicenter clinical trial

17 September 2019

main subject

1 reference

inferred from title

phase III clinical trial

1 reference

1 reference

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1290019

9 September 2022

publication date

1 January 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1290019 AND SRC:MED&resulttype=core&format=json

Rheumatology International

17 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1290019 AND SRC:MED&resulttype=core&format=json

17 September 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1290019 AND SRC:MED&resulttype=core&format=json

17 September 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1290019 AND SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

175-185

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1290019 AND SRC:MED&resulttype=core&format=json

Low-dose gamma interferon in treatment of rheumatoid arthritis

17 September 2019

cites work

1 reference

12 December 2020

1 reference

12 December 2020

Biologic activities of interleukin-1 relevant to rheumatic diseases

1 reference

12 December 2020

Comment on the articles by Firestein and Zvaifler

1 reference

12 December 2020

Quantitative analysis of cytokine gene expression in rheumatoid arthritis

1 reference

12 December 2020

Interferon-gamma in the therapy of chronic polyarthritis

1 reference

12 December 2020

Report of a three-year study on the systemic and articular indexes in rheumatoid arthritis; theoretic and clinical considerations

1 reference

12 December 2020

Spontaneous and LPS-stimulated production of intracellular IL-1 beta by synovial macrophages in rheumatoid arthritis is inhibited by IFN-gamma

1 reference

12 December 2020

Cloning and structure of the human immune interferon-gamma chromosomal gene

1 reference

12 December 2020

[Synovial level of interleukin 1 and C3a in chronic polyarthritis, psoriatic arthritis and activated arthritis]

1 reference

12 December 2020

Interleukin-1-like activities in synovial fluids of patients with rheumatoid arthritis and traumatic synovitis

1 reference

12 December 2020

Interferon gamma in the treatment of chronic polyarthritis. Long-term therapy in clinical practice

1 reference

12 December 2020

The biology of interferon actions

1 reference

12 December 2020

Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis

1 reference

12 December 2020

Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

1 reference

12 December 2020

Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. II. Low levels of synovial fluid and synovial tissue interferon suggest that gamma-interferon is not the primary macrophage activating factor

1 reference

12 December 2020

The potential role of interferons and interferon antagonists in inflammatory disease

1 reference

12 December 2020

Detection of activated T cell products in the rheumatoid joint using cDNA probes to Interleukin-2 (IL-2) IL-2 receptor and IFN-gamma

1 reference

12 December 2020

Prospective two-year followup of recombinant interferon-gamma in rheumatoid arthritis

1 reference

12 December 2020

Interleukin-1 release by rat synovial cells is dependent on sequential treatment with gamma-interferon and lipopolysaccharide

1 reference

12 December 2020

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

12 December 2020

1958 Revision of diagnostic criteria for rheumatoid arthritis

1 reference

12 December 2020

Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis. 1989.

1 reference

12 December 2020

Biology of interleukin 1.

1 reference

12 December 2020

Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients. Possible involvement in joint destruction

1 reference

12 December 2020

Correlation of clinical and serological findings in patients with rheumatoid arthritis treated for one year with interferon-gamma

1 reference

12 December 2020

Results of a multicenter placebo-controlled double-blind randomized phase III clinical study of treatment of rheumatoid arthritis with recombinant interferon-gamma

1 reference

12 December 2020

Regulation of interleukin 1 production by mouse peritoneal macrophages. Effects of arachidonic acid metabolites, cyclic nucleotides, and interferons

1 reference

12 December 2020

The modulation of interleukin 1 production by interferon gamma, and the inhibitory effects of gold compounds

1 reference

12 December 2020

Interferon in chronic polyarthritis. Positive effect in clinical evaluation

1 reference

12 December 2020

Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon.

1 reference

12 December 2020

Occurrence of interleukin-1 in human synovial fluid: detection by RIA, bioassay and presence of bioassay-inhibiting factors

1 reference

12 December 2020

IL-1 induces IL-1. III. Specific inhibition of IL-1 production by IFN-gamma

1 reference

12 December 2020

Results of a phase-II clinical trial on treatment of rheumatoid arthritis with recombinant interferon-gamma.

1 reference

12 December 2020

High-level expression of human interferon gamma in Escherichia coli under control of the pL promoter of bacteriophage lambda

1 reference

12 December 2020

Structure of the human immune interferon gene

1 reference

12 December 2020

Evaluation Of A Functional Index In Rheumatoid Arthritis

1 reference

12 December 2020

Prostaglandin E2, interleukin 1 and gamma interferon production of mononuclear cells of patients with inflammatory and degenerative joint diseases

1 reference

12 December 2020

Cytokine regulation of human monocyte interleukin-1 (IL-1) production in vitro. Enhancement of IL-1 production by interferon (IFN) gamma, tumour necrosis factor-alpha, IL-2 and IL-1, and inhibition by IFN-alpha

1 reference

12 December 2020

[Therapy of rheumatoid arthritis with recombinant gamma interferon. Clinical course and laboratory parameters in one year's treatment]

1 reference

12 December 2020

[Immunomodulating therapy in chronic polyarthritis with thymopentin. A multicenter placebo-controlled study of 119 patients]

1 reference

12 December 2020

Interferon gamma: a Janus-faced mediator in inflammation

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00302149

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1290019

9 September 2022

1 reference